Corcept Therapeutics Incorporated · NASDAQ:CORT
Belanoff Joseph K sold 40,000 Corcept Therapeutics Incorporated shares (Form 4)
Traded May 1, 2026 · Filed May 5, 2026
On May 1, 2026, Belanoff Joseph K (Director, Chief Executive Officer) sold 40,000 Corcept Therapeutics Incorporated shares at US$50.10 for US$2M under a trading plan, leaving 2,878,326 shares. Filed May 5, 2026 (Form 4).
- Sold
- 40,000 shares
- Price
- US$50.10
- Value
- US$2M
- Holding after
- 2,878,326 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | Sale | 40,000 | US$50.10 | 2,878,326 | Indirect |
Source
Related
- Corcept Therapeutics Incorporated
- Belanoff Joseph K
- Corcept Therapeutics Incorporated shareholders
- Form 4 · Belanoff Joseph K · Jun 2, 2026
- Form 4 · Wilson James N · Oct 16, 2026
- Form 4 · Vieira Roberto Wandenkolk · Oct 5, 2026
- Form 4 · Maduck Sean · Oct 5, 2026
- Form 4 · Lyon Joseph Douglas · Oct 5, 2026
- Form 4 · Robb Gary Charles · Sep 28, 2026